Women’s Health – Uterine Fibroids and Heavy Menstrual Bleeding
As the most common type of non-cancerous tumors in women of reproductive age, uterine fibroids can cause physical symptoms, including heavy menstrual bleeding. Additionally, uterine fibroids can take a significant toll on quality of life, relationships and intimacy, employment, and create an overall reduced quality of well-being in a patient’s health. Dr. Veronica Gillispie-Bell, Senior Site Lead and Section Head of Obstetrics and Gynecology at Ochsner Kenner in New Orleans discusses heavy menstrual bleeding as a symptom of uterine fibroids, options in the treatment landscape, including ORIAHNN™, the first, non-surgical, oral medication developed specifically to treat heavy menstrual bleeding associated with uterine fibroids in premenopausal patients. She also shares how HCPs can open a dialogue with patients about their individual symptoms, lifestyle and treatment goals, and to address their concerns sooner rather than later.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Veronica Gillispie-Bell, MD, MS, is a practicing ob-gyn and section head of women’s services at Ochsner Kenner in New Orleans. She is the Medical Director of the Louisiana Perinatal Quality Collaborative (LaPQC) and Pregnancy Associated Mortality Review with the LA Department of Health. She is an associate professor and director of the Center for Minimally Invasive Treatment of Uterine Fibroids.
Dr. Veronica Gillispie-Bell is a Board-Certified Obstetrician & Gynecologist and Associate Professor for Ochsner Health in New Orleans, Louisiana. She serves as the Senior Site Lead and Section Head of Obstetrics and Gynecology at Ochsner Kenner. Additionally, she serves as the Director of Quality for Women’s Services for the Ochsner Health System and is an associate professor and director of the Center for Minimally Invasive Treatment of Uterine Fibroids. Dr. Gillispie-Bell is also the Medical Director of the Louisiana Perinatal Quality Collaborative and Pregnancy Associated Mortality Review for the Louisiana Department of Health.
She earned her medical degree from Meharry Medical College and completed her residency training at Ochsner Health System. She also earned a Master of Applied Science in Patient Safety and Healthcare Quality from the Johns Hopkins Bloomberg School of Public Health. Additionally, she has received certification in Diversity and Inclusion from Cornell University
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
